64406-030 : Zurzuvae 25 mg Oral Capsule
| NDC: | 64406-030 |
| Labeler: | Biogen Ma Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Zurzuvae |
| Dosage Form: | Oral Capsule |
| Application #: | NDA217369 |
| Rev. Date: | |
| CSA Schedule: | CIV (US) [1] |
[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.
NDC Package Codes:
- 64406-030-01: 1 BOTTLE IN 1 CARTON (64406‑030‑01) / 14 CAPSULE IN 1 BOTTLE
- 64406-030-02: 1 CARTON IN 1 CARTON (64406‑030‑02) / 1 BLISTER PACK IN 1 CARTON / 28 CAPSULE IN 1 BLISTER PACK
Active Ingredients:
- Zuranolone
Dosage Strength:
- 25 mg
Pharmaceutical Classes:
- GABA A Receptor Positive Modulators [MoA]
- Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
Related Products:
Based on records with the same trade name.- 64406-029 Zurzuvae 20 mg Oral Capsule by Biogen Ma Inc.
- 64406-031 Zurzuvae 30 mg Oral Capsule by Biogen Ma Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 64406-029Next: 64406-031 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.